Literature DB >> 28764158

Salivary Anti-50 kDa Antibodies as a Useful Biomarker for Diagnosis of Typhoid Fever.

Nur Eliyana Mohd Redhuan1, Kai Ling Chin2, Azreen Syazril Adnan3, Asma Ismail4, Prabha Balaram4, Kia Kien Phua5.   

Abstract

INTRODUCTION: Typhoid fever remains a scourge of humanity, especially in developing and under-developed countries due to poor sanitation and food hygiene. Diagnostic methods available for detection of this disease are not satisfactory due to a lack of sensitive, specific, rapid and convenient diagnostic test kits available in the market. AIM: To evaluate the feasibility of a Dot-EIA method for Ig-class specific salivary antibody detection for diagnosis of typhoid fever.
MATERIALS AND METHODS: Paired saliva and serum samples were collected in the year 2010 from patients and normal volunteers in Hospital Universiti Sains Malaysia, Kelantan, Malaysia, which is endemic for typhoid fever. A total of 11 culture-confirmed typhoid fever patients, 43 non-typhoid fever patients and 53 normal human control subjects were evaluated for antibodies against a 50 kDa antigen specific for Salmonella Typhi using Dot-EIA.
RESULTS: Ig class-specific screening of the test samples showed a higher sensitivity for IgA (90.9%) compared to either IgG (72.7%) or IgM (72.7%) antibodies in saliva, but for serum, IgG (90.9%) had a higher degree of sensitivity compared to IgA (36.4%) and IgM (63.6%). Combining all isotypes (IgA, IgG or IgM), serum showed a higher sensitivity (100.0%) compared to saliva (90.9%). Also, the specificity for serum (100.0%) was much higher than saliva (85.4%).
CONCLUSION: Salivary IgA anti-50kDa antibody was found to be more suitable biomarker for routine screening, whereas serum IgG was more suitable for confirmatory test as it has higher specificity. Nevertheless, salivary IgA Dot-EIA is a convenient method for rapid testing, such as for Point-of-Care Diagnostics (POCD) and field epidemiological studies, due to its non-invasive nature and ease of use.

Entities:  

Keywords:  Dot-EIA; Saliva; Salmonella Typhi; Widal

Year:  2017        PMID: 28764158      PMCID: PMC5535351          DOI: 10.7860/JCDR/2017/21928.10055

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  33 in total

1.  Salivary IgA and IgE levels in healthy subjects: relation to age and gender.

Authors:  Abdollah Jafarzadeh; Mostafa Sadeghi; Gholamreza Asadi Karam; Reza Vazirinejad
Journal:  Braz Oral Res       Date:  2010 Jan-Mar

2.  Global programme on AIDS. Recommendations for the selection and use of HIV antibody tests.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1992-05-15

Review 3.  Saliva as research material: biochemical, physicochemical and practical aspects.

Authors:  Raymond G Schipper; Erika Silletti; Monique H Vingerhoeds
Journal:  Arch Oral Biol       Date:  2007-08-10       Impact factor: 2.633

Review 4.  Salivary proteomics in biomedical research.

Authors:  Aihua Zhang; Hui Sun; Ping Wang; Xijun Wang
Journal:  Clin Chim Acta       Date:  2012-11-09       Impact factor: 3.786

5.  Evaluation of salivary anti-Salmonella typhi lipopolysaccharide IgA ELISA for serodiagnosis of typhoid fever in children.

Authors:  Zeeba Zaka-ur-Rab; Shaad Abqari; Tabassum Shahab; Najmul Islam; Indu Shukla
Journal:  Arch Dis Child       Date:  2012-01-03       Impact factor: 3.791

6.  Detection of Salivary IgA Antibodies Against the HlyE Antigen as a Diagnosis of Typhoid Fever.

Authors:  Kai Ling Chin; Nur Eliyana Mohd Redhuan; Prabha Balaram; Kia Kien Phua; Eugene Boon Beng Ong
Journal:  J Clin Diagn Res       Date:  2016-06-01

7.  Early diagnosis of typhoid fever by the detection of salivary IgA.

Authors:  H M T U Herath
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

Review 8.  Saliva: an emerging biofluid for early detection of diseases.

Authors:  Yu-Hsiang Lee; David T Wong
Journal:  Am J Dent       Date:  2009-08       Impact factor: 1.522

9.  Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.

Authors:  Anu Nurkka; Mika Lahdenkari; Arto A I Palmu; Helena Käyhty
Journal:  BMC Infect Dis       Date:  2005-05-27       Impact factor: 3.090

10.  Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010.

Authors:  Geoffrey C Buckle; Christa L Fischer Walker; Robert E Black
Journal:  J Glob Health       Date:  2012-06       Impact factor: 4.413

View more
  1 in total

Review 1.  Post-fever retinitis - Newer concepts.

Authors:  Padmamalini Mahendradas; Ankush Kawali; Saurabh Luthra; Sanjay Srinivasan; Andre L Curi; Shrey Maheswari; Imen Ksiaa; Moncef Khairallah
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.